{"entity":{"type":"insider","cik":"0001442757","url":"/insider/0001442757","json_url":"/insider/0001442757.json","name":"Savitr Capital, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":26,"n_filings":1,"first":"2015-02-12","last":"2015-02-12","span_basis":"filed_date"},"name_variants":[{"name":"Savitr Capital, LLC","source":"filing","n_filings":1,"first_seen":"2015-02-12","last_seen":"2015-02-12"}],"transactions":[{"id":8831882,"accession":"0001442757-15-000002","txn_seq":26,"anchor":"line-26","filing_url":"/filing/0001442757-15-000002","line_url":"/filing/0001442757-15-000002#line-26","is_derivative":false,"issuer_cik":"0000818033","issuer_name":"HERON THERAPEUTICS, INC. /DE/","issuer_ticker":"HRTX","issuer_name_source":null,"issuer_url":"/issuer/0000818033","owner_cik":"0001442757","owner_name":"Savitr Capital, LLC","owner_display_name":"Savitr Capital, LLC","owner_url":"/insider/0001442757","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Heron Therapeutics Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":9.8,"price_display":"9.80","price_state":"stated","total_value":9800.0,"total_display":"9,800.00","total_whole":"9,800","shares_owned_after":1712366.0,"shares_owned_after_display":"1,712,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-23","filed_date":"2015-02-12","scope":"insider"},{"id":8831878,"accession":"0001442757-15-000002","txn_seq":25,"anchor":"line-25","filing_url":"/filing/0001442757-15-000002","line_url":"/filing/0001442757-15-000002#line-25","is_derivative":false,"issuer_cik":"0000818033","issuer_name":"HERON THERAPEUTICS, INC. /DE/","issuer_ticker":"HRTX","issuer_name_source":null,"issuer_url":"/issuer/0000818033","owner_cik":"0001442757","owner_name":"Savitr Capital, LLC","owner_display_name":"Savitr Capital, LLC","owner_url":"/insider/0001442757","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Heron Therapeutics Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":9.6515,"price_display":"9.65","price_state":"stated","total_value":19303.0,"total_display":"19,303.00","total_whole":"19,303","shares_owned_after":1712366.0,"shares_owned_after_display":"1,712,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-22","filed_date":"2015-02-12","scope":"insider"},{"id":8831876,"accession":"0001442757-15-000002","txn_seq":24,"anchor":"line-24","filing_url":"/filing/0001442757-15-000002","line_url":"/filing/0001442757-15-000002#line-24","is_derivative":false,"issuer_cik":"0000818033","issuer_name":"HERON THERAPEUTICS, INC. /DE/","issuer_ticker":"HRTX","issuer_name_source":null,"issuer_url":"/issuer/0000818033","owner_cik":"0001442757","owner_name":"Savitr Capital, LLC","owner_display_name":"Savitr Capital, LLC","owner_url":"/insider/0001442757","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Heron Therapeutics Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":9.33,"price_display":"9.33","price_state":"stated","total_value":9330.0,"total_display":"9,330.00","total_whole":"9,330","shares_owned_after":1712366.0,"shares_owned_after_display":"1,712,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-19","filed_date":"2015-02-12","scope":"insider"},{"id":8831874,"accession":"0001442757-15-000002","txn_seq":23,"anchor":"line-23","filing_url":"/filing/0001442757-15-000002","line_url":"/filing/0001442757-15-000002#line-23","is_derivative":false,"issuer_cik":"0000818033","issuer_name":"HERON THERAPEUTICS, INC. /DE/","issuer_ticker":"HRTX","issuer_name_source":null,"issuer_url":"/issuer/0000818033","owner_cik":"0001442757","owner_name":"Savitr Capital, LLC","owner_display_name":"Savitr Capital, LLC","owner_url":"/insider/0001442757","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Heron Therapeutics Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":9.24,"price_display":"9.24","price_state":"stated","total_value":9240.0,"total_display":"9,240.00","total_whole":"9,240","shares_owned_after":1712366.0,"shares_owned_after_display":"1,712,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-17","filed_date":"2015-02-12","scope":"insider"},{"id":8831871,"accession":"0001442757-15-000002","txn_seq":22,"anchor":"line-22","filing_url":"/filing/0001442757-15-000002","line_url":"/filing/0001442757-15-000002#line-22","is_derivative":false,"issuer_cik":"0000818033","issuer_name":"HERON THERAPEUTICS, INC. /DE/","issuer_ticker":"HRTX","issuer_name_source":null,"issuer_url":"/issuer/0000818033","owner_cik":"0001442757","owner_name":"Savitr Capital, LLC","owner_display_name":"Savitr Capital, LLC","owner_url":"/insider/0001442757","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Heron Therapeutics Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3700.0,"shares_display":"3,700","price_per_share":9.3573,"price_display":"9.36","price_state":"stated","total_value":34622.01,"total_display":"34,622.01","total_whole":"34,622","shares_owned_after":1712366.0,"shares_owned_after_display":"1,712,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-16","filed_date":"2015-02-12","scope":"insider"},{"id":8831868,"accession":"0001442757-15-000002","txn_seq":21,"anchor":"line-21","filing_url":"/filing/0001442757-15-000002","line_url":"/filing/0001442757-15-000002#line-21","is_derivative":false,"issuer_cik":"0000818033","issuer_name":"HERON THERAPEUTICS, INC. /DE/","issuer_ticker":"HRTX","issuer_name_source":null,"issuer_url":"/issuer/0000818033","owner_cik":"0001442757","owner_name":"Savitr Capital, LLC","owner_display_name":"Savitr Capital, LLC","owner_url":"/insider/0001442757","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Heron Therapeutics Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":7.42,"price_display":"7.42","price_state":"stated","total_value":7420.0,"total_display":"7,420.00","total_whole":"7,420","shares_owned_after":1712366.0,"shares_owned_after_display":"1,712,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-10-24","filed_date":"2015-02-12","scope":"insider"},{"id":8831866,"accession":"0001442757-15-000002","txn_seq":20,"anchor":"line-20","filing_url":"/filing/0001442757-15-000002","line_url":"/filing/0001442757-15-000002#line-20","is_derivative":false,"issuer_cik":"0000818033","issuer_name":"HERON THERAPEUTICS, INC. /DE/","issuer_ticker":"HRTX","issuer_name_source":null,"issuer_url":"/issuer/0000818033","owner_cik":"0001442757","owner_name":"Savitr Capital, LLC","owner_display_name":"Savitr Capital, LLC","owner_url":"/insider/0001442757","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Heron Therapeutics Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":8.4005,"price_display":"8.40","price_state":"stated","total_value":8400.5,"total_display":"8,400.50","total_whole":"8,401","shares_owned_after":1712366.0,"shares_owned_after_display":"1,712,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-30","filed_date":"2015-02-12","scope":"insider"},{"id":8831861,"accession":"0001442757-15-000002","txn_seq":19,"anchor":"line-19","filing_url":"/filing/0001442757-15-000002","line_url":"/filing/0001442757-15-000002#line-19","is_derivative":false,"issuer_cik":"0000818033","issuer_name":"HERON THERAPEUTICS, INC. /DE/","issuer_ticker":"HRTX","issuer_name_source":null,"issuer_url":"/issuer/0000818033","owner_cik":"0001442757","owner_name":"Savitr Capital, LLC","owner_display_name":"Savitr Capital, LLC","owner_url":"/insider/0001442757","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Heron Therapeutics Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":8.7653,"price_display":"8.77","price_state":"stated","total_value":26295.9,"total_display":"26,295.90","total_whole":"26,296","shares_owned_after":1712366.0,"shares_owned_after_display":"1,712,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-29","filed_date":"2015-02-12","scope":"insider"},{"id":8831858,"accession":"0001442757-15-000002","txn_seq":18,"anchor":"line-18","filing_url":"/filing/0001442757-15-000002","line_url":"/filing/0001442757-15-000002#line-18","is_derivative":false,"issuer_cik":"0000818033","issuer_name":"HERON THERAPEUTICS, INC. /DE/","issuer_ticker":"HRTX","issuer_name_source":null,"issuer_url":"/issuer/0000818033","owner_cik":"0001442757","owner_name":"Savitr Capital, LLC","owner_display_name":"Savitr Capital, LLC","owner_url":"/insider/0001442757","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Heron Therapeutics Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":8.52,"price_display":"8.52","price_state":"stated","total_value":8520.0,"total_display":"8,520.00","total_whole":"8,520","shares_owned_after":1712366.0,"shares_owned_after_display":"1,712,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-26","filed_date":"2015-02-12","scope":"insider"},{"id":8831856,"accession":"0001442757-15-000002","txn_seq":17,"anchor":"line-17","filing_url":"/filing/0001442757-15-000002","line_url":"/filing/0001442757-15-000002#line-17","is_derivative":false,"issuer_cik":"0000818033","issuer_name":"HERON THERAPEUTICS, INC. /DE/","issuer_ticker":"HRTX","issuer_name_source":null,"issuer_url":"/issuer/0000818033","owner_cik":"0001442757","owner_name":"Savitr Capital, LLC","owner_display_name":"Savitr Capital, LLC","owner_url":"/insider/0001442757","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Heron Therapeutics Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":8.55,"price_display":"8.55","price_state":"stated","total_value":8550.0,"total_display":"8,550.00","total_whole":"8,550","shares_owned_after":1712366.0,"shares_owned_after_display":"1,712,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-24","filed_date":"2015-02-12","scope":"insider"},{"id":8831854,"accession":"0001442757-15-000002","txn_seq":16,"anchor":"line-16","filing_url":"/filing/0001442757-15-000002","line_url":"/filing/0001442757-15-000002#line-16","is_derivative":false,"issuer_cik":"0000818033","issuer_name":"HERON THERAPEUTICS, INC. /DE/","issuer_ticker":"HRTX","issuer_name_source":null,"issuer_url":"/issuer/0000818033","owner_cik":"0001442757","owner_name":"Savitr Capital, LLC","owner_display_name":"Savitr Capital, LLC","owner_url":"/insider/0001442757","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Heron Therapeutics Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10.0,"shares_display":"10","price_per_share":9.1,"price_display":"9.10","price_state":"stated","total_value":91.0,"total_display":"91.00","total_whole":"91","shares_owned_after":1712366.0,"shares_owned_after_display":"1,712,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-09-19","filed_date":"2015-02-12","scope":"insider"},{"id":8831852,"accession":"0001442757-15-000002","txn_seq":15,"anchor":"line-15","filing_url":"/filing/0001442757-15-000002","line_url":"/filing/0001442757-15-000002#line-15","is_derivative":false,"issuer_cik":"0000818033","issuer_name":"HERON THERAPEUTICS, INC. /DE/","issuer_ticker":"HRTX","issuer_name_source":null,"issuer_url":"/issuer/0000818033","owner_cik":"0001442757","owner_name":"Savitr Capital, LLC","owner_display_name":"Savitr Capital, LLC","owner_url":"/insider/0001442757","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Heron Therapeutics Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":9.2848,"price_display":"9.28","price_state":"stated","total_value":9284.8,"total_display":"9,284.80","total_whole":"9,285","shares_owned_after":1712366.0,"shares_owned_after_display":"1,712,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-31","filed_date":"2015-02-12","scope":"insider"},{"id":8831850,"accession":"0001442757-15-000002","txn_seq":14,"anchor":"line-14","filing_url":"/filing/0001442757-15-000002","line_url":"/filing/0001442757-15-000002#line-14","is_derivative":false,"issuer_cik":"0000818033","issuer_name":"HERON THERAPEUTICS, INC. /DE/","issuer_ticker":"HRTX","issuer_name_source":null,"issuer_url":"/issuer/0000818033","owner_cik":"0001442757","owner_name":"Savitr Capital, LLC","owner_display_name":"Savitr Capital, LLC","owner_url":"/insider/0001442757","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Heron Therapeutics Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":9.1967,"price_display":"9.20","price_state":"stated","total_value":27590.1,"total_display":"27,590.10","total_whole":"27,590","shares_owned_after":1712366.0,"shares_owned_after_display":"1,712,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-30","filed_date":"2015-02-12","scope":"insider"},{"id":8831848,"accession":"0001442757-15-000002","txn_seq":13,"anchor":"line-13","filing_url":"/filing/0001442757-15-000002","line_url":"/filing/0001442757-15-000002#line-13","is_derivative":false,"issuer_cik":"0000818033","issuer_name":"HERON THERAPEUTICS, INC. /DE/","issuer_ticker":"HRTX","issuer_name_source":null,"issuer_url":"/issuer/0000818033","owner_cik":"0001442757","owner_name":"Savitr Capital, LLC","owner_display_name":"Savitr Capital, LLC","owner_url":"/insider/0001442757","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Heron Therapeutics Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":9.097,"price_display":"9.10","price_state":"stated","total_value":36388.0,"total_display":"36,388.00","total_whole":"36,388","shares_owned_after":1712366.0,"shares_owned_after_display":"1,712,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-29","filed_date":"2015-02-12","scope":"insider"},{"id":8831845,"accession":"0001442757-15-000002","txn_seq":12,"anchor":"line-12","filing_url":"/filing/0001442757-15-000002","line_url":"/filing/0001442757-15-000002#line-12","is_derivative":false,"issuer_cik":"0000818033","issuer_name":"HERON THERAPEUTICS, INC. /DE/","issuer_ticker":"HRTX","issuer_name_source":null,"issuer_url":"/issuer/0000818033","owner_cik":"0001442757","owner_name":"Savitr Capital, LLC","owner_display_name":"Savitr Capital, LLC","owner_url":"/insider/0001442757","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Heron Therapeutics Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":9.0317,"price_display":"9.03","price_state":"stated","total_value":27095.1,"total_display":"27,095.10","total_whole":"27,095","shares_owned_after":1712366.0,"shares_owned_after_display":"1,712,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-25","filed_date":"2015-02-12","scope":"insider"},{"id":8831842,"accession":"0001442757-15-000002","txn_seq":11,"anchor":"line-11","filing_url":"/filing/0001442757-15-000002","line_url":"/filing/0001442757-15-000002#line-11","is_derivative":false,"issuer_cik":"0000818033","issuer_name":"HERON THERAPEUTICS, INC. /DE/","issuer_ticker":"HRTX","issuer_name_source":null,"issuer_url":"/issuer/0000818033","owner_cik":"0001442757","owner_name":"Savitr Capital, LLC","owner_display_name":"Savitr Capital, LLC","owner_url":"/insider/0001442757","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Heron Therapeutics Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3300.0,"shares_display":"3,300","price_per_share":12.4502,"price_display":"12.45","price_state":"stated","total_value":41085.66,"total_display":"41,085.66","total_whole":"41,086","shares_owned_after":1712366.0,"shares_owned_after_display":"1,712,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-07-03","filed_date":"2015-02-12","scope":"insider"},{"id":8831840,"accession":"0001442757-15-000002","txn_seq":10,"anchor":"line-10","filing_url":"/filing/0001442757-15-000002","line_url":"/filing/0001442757-15-000002#line-10","is_derivative":false,"issuer_cik":"0000818033","issuer_name":"HERON THERAPEUTICS, INC. /DE/","issuer_ticker":"HRTX","issuer_name_source":null,"issuer_url":"/issuer/0000818033","owner_cik":"0001442757","owner_name":"Savitr Capital, LLC","owner_display_name":"Savitr Capital, LLC","owner_url":"/insider/0001442757","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Heron Therapeutics Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19147.0,"shares_display":"19,147","price_per_share":12.8187,"price_display":"12.82","price_state":"stated","total_value":245439.6489,"total_display":"245,439.65","total_whole":"245,440","shares_owned_after":1712366.0,"shares_owned_after_display":"1,712,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-06-24","filed_date":"2015-02-12","scope":"insider"},{"id":8831838,"accession":"0001442757-15-000002","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001442757-15-000002","line_url":"/filing/0001442757-15-000002#line-9","is_derivative":false,"issuer_cik":"0000818033","issuer_name":"HERON THERAPEUTICS, INC. /DE/","issuer_ticker":"HRTX","issuer_name_source":null,"issuer_url":"/issuer/0000818033","owner_cik":"0001442757","owner_name":"Savitr Capital, LLC","owner_display_name":"Savitr Capital, LLC","owner_url":"/insider/0001442757","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Heron Therapeutics Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":14.33,"price_display":"14.33","price_state":"stated","total_value":14330.0,"total_display":"14,330.00","total_whole":"14,330","shares_owned_after":1712366.0,"shares_owned_after_display":"1,712,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-27","filed_date":"2015-02-12","scope":"insider"},{"id":8831836,"accession":"0001442757-15-000002","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001442757-15-000002","line_url":"/filing/0001442757-15-000002#line-8","is_derivative":false,"issuer_cik":"0000818033","issuer_name":"HERON THERAPEUTICS, INC. /DE/","issuer_ticker":"HRTX","issuer_name_source":null,"issuer_url":"/issuer/0000818033","owner_cik":"0001442757","owner_name":"Savitr Capital, LLC","owner_display_name":"Savitr Capital, LLC","owner_url":"/insider/0001442757","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Heron Therapeutics Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":14.1001,"price_display":"14.10","price_state":"stated","total_value":56400.4,"total_display":"56,400.40","total_whole":"56,400","shares_owned_after":1712366.0,"shares_owned_after_display":"1,712,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-25","filed_date":"2015-02-12","scope":"insider"},{"id":8831834,"accession":"0001442757-15-000002","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001442757-15-000002","line_url":"/filing/0001442757-15-000002#line-7","is_derivative":false,"issuer_cik":"0000818033","issuer_name":"HERON THERAPEUTICS, INC. /DE/","issuer_ticker":"HRTX","issuer_name_source":null,"issuer_url":"/issuer/0000818033","owner_cik":"0001442757","owner_name":"Savitr Capital, LLC","owner_display_name":"Savitr Capital, LLC","owner_url":"/insider/0001442757","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Heron Therapeutics Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":15.3038,"price_display":"15.30","price_state":"stated","total_value":45911.4,"total_display":"45,911.40","total_whole":"45,911","shares_owned_after":1712366.0,"shares_owned_after_display":"1,712,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-21","filed_date":"2015-02-12","scope":"insider"},{"id":8831832,"accession":"0001442757-15-000002","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001442757-15-000002","line_url":"/filing/0001442757-15-000002#line-6","is_derivative":false,"issuer_cik":"0000818033","issuer_name":"HERON THERAPEUTICS, INC. /DE/","issuer_ticker":"HRTX","issuer_name_source":null,"issuer_url":"/issuer/0000818033","owner_cik":"0001442757","owner_name":"Savitr Capital, LLC","owner_display_name":"Savitr Capital, LLC","owner_url":"/insider/0001442757","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Heron Therapeutics Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":15.5801,"price_display":"15.58","price_state":"stated","total_value":77900.5,"total_display":"77,900.50","total_whole":"77,901","shares_owned_after":1712366.0,"shares_owned_after_display":"1,712,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-20","filed_date":"2015-02-12","scope":"insider"},{"id":8831830,"accession":"0001442757-15-000002","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001442757-15-000002","line_url":"/filing/0001442757-15-000002#line-5","is_derivative":false,"issuer_cik":"0000818033","issuer_name":"HERON THERAPEUTICS, INC. /DE/","issuer_ticker":"HRTX","issuer_name_source":null,"issuer_url":"/issuer/0000818033","owner_cik":"0001442757","owner_name":"Savitr Capital, LLC","owner_display_name":"Savitr Capital, LLC","owner_url":"/insider/0001442757","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Heron Therapeutics Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":15.5307,"price_display":"15.53","price_state":"stated","total_value":155307.0,"total_display":"155,307.00","total_whole":"155,307","shares_owned_after":1712366.0,"shares_owned_after_display":"1,712,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-19","filed_date":"2015-02-12","scope":"insider"},{"id":8831829,"accession":"0001442757-15-000002","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001442757-15-000002","line_url":"/filing/0001442757-15-000002#line-4","is_derivative":false,"issuer_cik":"0000818033","issuer_name":"HERON THERAPEUTICS, INC. /DE/","issuer_ticker":"HRTX","issuer_name_source":null,"issuer_url":"/issuer/0000818033","owner_cik":"0001442757","owner_name":"Savitr Capital, LLC","owner_display_name":"Savitr Capital, LLC","owner_url":"/insider/0001442757","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Heron Therapeutics Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":15.1757,"price_display":"15.18","price_state":"stated","total_value":151757.0,"total_display":"151,757.00","total_whole":"151,757","shares_owned_after":1712366.0,"shares_owned_after_display":"1,712,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-18","filed_date":"2015-02-12","scope":"insider"},{"id":8831827,"accession":"0001442757-15-000002","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001442757-15-000002","line_url":"/filing/0001442757-15-000002#line-3","is_derivative":false,"issuer_cik":"0000818033","issuer_name":"HERON THERAPEUTICS, INC. /DE/","issuer_ticker":"HRTX","issuer_name_source":null,"issuer_url":"/issuer/0000818033","owner_cik":"0001442757","owner_name":"Savitr Capital, LLC","owner_display_name":"Savitr Capital, LLC","owner_url":"/insider/0001442757","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Heron Therapeutics Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":14.8562,"price_display":"14.86","price_state":"stated","total_value":29712.4,"total_display":"29,712.40","total_whole":"29,712","shares_owned_after":1712366.0,"shares_owned_after_display":"1,712,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-14","filed_date":"2015-02-12","scope":"insider"},{"id":8831825,"accession":"0001442757-15-000002","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001442757-15-000002","line_url":"/filing/0001442757-15-000002#line-2","is_derivative":false,"issuer_cik":"0000818033","issuer_name":"HERON THERAPEUTICS, INC. /DE/","issuer_ticker":"HRTX","issuer_name_source":null,"issuer_url":"/issuer/0000818033","owner_cik":"0001442757","owner_name":"Savitr Capital, LLC","owner_display_name":"Savitr Capital, LLC","owner_url":"/insider/0001442757","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Heron Therapeutics Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":14.5693,"price_display":"14.57","price_state":"stated","total_value":58277.2,"total_display":"58,277.20","total_whole":"58,277","shares_owned_after":1712366.0,"shares_owned_after_display":"1,712,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-13","filed_date":"2015-02-12","scope":"insider"},{"id":8831822,"accession":"0001442757-15-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001442757-15-000002","line_url":"/filing/0001442757-15-000002#line-1","is_derivative":false,"issuer_cik":"0000818033","issuer_name":"HERON THERAPEUTICS, INC. /DE/","issuer_ticker":"HRTX","issuer_name_source":null,"issuer_url":"/issuer/0000818033","owner_cik":"0001442757","owner_name":"Savitr Capital, LLC","owner_display_name":"Savitr Capital, LLC","owner_url":"/insider/0001442757","role":"Other","role_mark":"*","role_mark_label":"Other","role_mark_generic":"Other","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Heron Therapeutics Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9000.0,"shares_display":"9,000","price_per_share":14.4677,"price_display":"14.47","price_state":"stated","total_value":130209.3,"total_display":"130,209.30","total_whole":"130,209","shares_owned_after":1712366.0,"shares_owned_after_display":"1,712,366","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-03-12","filed_date":"2015-02-12","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":26,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":26,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":26},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000818033","name":"HERON THERAPEUTICS, INC. /DE/","url":"/issuer/0000818033","role":"Other","n_filings":1,"first_seen":"2015-02-12","last_seen":"2015-02-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001442757","retrieved_at":"2026-08-25T23:26:06+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}